secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2024-12-18T23:59:59+00:00
Accession:  0001437749-24-037764
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva prices $18M public offering of 12M shares and warrants
-------------------------------------------------------------

- Offering of 12M shares of common stock plus Series A warrants (6M shares, 6-month term) and Series B warrants (12M shares, 5-year term) at $1.50/unit.
- Gross proceeds $18M; net proceeds ~$15.8M after underwriting discounts and expenses.
- Series A warrants exercisable at $1.50, expire in 6 months; Series B warrants at $1.50, expire in 5 years.
- Expected closing on December 18, 2024; Citizens JMP Securities is sole bookrunner.
- Proceeds to fund R&D, working capital, and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924037764/0001437749-24-037764-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924037764/rvph20241217_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-037764

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer